Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14BrNO2 |
| Molecular Weight | 260.128 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CCN)=C(OC)C=C1Br
InChI
InChIKey=YMHOBZXQZVXHBM-UHFFFAOYSA-N
InChI=1S/C10H14BrNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3
| Molecular Formula | C10H14BrNO2 |
| Molecular Weight | 260.128 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| WHO Expert Committee on Drug Dependence. Thirty-second report. | 2001 |
|
| Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry. | 2002 Jan |
|
| In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. | 2002 Mar |
|
| 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. | 2002 Oct-Dec |
|
| 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes. | 2004 Apr |
|
| Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis. | 2004 Mar |
|
| Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration. | 2004 Nov 25 |
|
| A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. | 2004 Sep |
|
| Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human. | 2005 Jan 5 |
|
| A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. | 2005 Mar 10 |
|
| Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection. | 2006 Jan 6 |
|
| Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines. | 2007 Dec |
|
| Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. | 2007 Feb 1 |
|
| Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. | 2008 Apr 21 |
|
| Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. | 2008 Jun 9 |
|
| Metabolism of designer drugs of abuse: an updated review. | 2010 Jun 1 |
|
| Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion. | 2010 May |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:10:20 UTC 2023
by
admin
on
Fri Dec 15 19:10:20 UTC 2023
|
| Record UNII |
V77772N32H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
7392
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-2C-B
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
V77772N32H
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
DB01537
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
66142-81-2
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
2C-B
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
DTXSID10216332
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
100000126036
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
SUB32985
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
98527
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | |||
|
m3180
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY | Merck Index | ||
|
189669
Created by
admin on Fri Dec 15 19:10:20 UTC 2023 , Edited by admin on Fri Dec 15 19:10:20 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
